In the past 10 years, there has been significant interest in new classes of active pharmaceutical ingredients (APIs). These novel APIs include live biotherapeutics, which are used for microbiome targeting drugs, oral biologics like GLP1 […]
COPENHAGEN, Denmark, Aug. 07, 2025 (GLOBE NEWSWIRE) — SNIPR Biome ApS (“SNIPR”), the company pioneering the development of microbial CRISPR-medicine, today announced the close of a EUR 35 million Series B raise with funding from […]
Postbiotics are a quickly-growing category of products targeting gut health and other applications, such as skin. Defined in 2021 as “a preparation of inanimate microorganisms and/or their components that confers a health benefit on the […]
The internationally recognized One Health Microbiome Center (OHMC) in the Huck Institutes of the Life Sciences at Penn State is the recipient of a new National Institutes of Health (NIH) grant to train doctoral students in biotechnological […]
As interest in biotics1 and their wide range of health applications continues to grow, BioGaia is proud to announce the launch of a subsidiary company, BioGaia New Sciences AB, dedicated to exploring opportunities in microbiome […]
A groundbreaking UK research network has been launched to uncover how the microbiota, gut, immune system and brain are inter-connected and how they can influence mental wellbeing. Work from the research network could potentially lead […]
MaaT Pharma announces the signature of a license and commercial agreement with Clinigen, a global specialty pharmaceutical services group and a leading European player in hospital distribution and market access, to streamline the pathway for […]
Researchers have been working toward using the gut microbiome as a clinical target for screening for colorectal cancer. This would ideally allow simple stool tests to be used for early detection of the disease in […]
Danone announces the acquisition of The Akkermansia Company (TAC), a Belgian company with nearly 20 years of history and science, specializing in biotics. In 2004, the team of Professor Willem M. de Vos at Wageningen University discovered, […]
Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global, diversified pharmaceutical company, announced today it has entered a strategic partnership with YUN NV, an innovative leader in microbiome skincare solutions. This collaboration is set to transform the […]
With Expert’Biome™, Lallemand Health Solutions aims to support partners in their development of next-generation strains by offering comprehensive services in the health industry. These services include strains research and development, bioprocesses scaling, drug manufacturing, and […]